Latest Quarterly or Annual Filing
Latest Current Report
Latest Proxy Statement
View All SEC Filings
View and filter by group or type
View All FilingsOcuphire Pharma Enters into a Global License Agreement for Development and Commercialization of Nyxol Eye Drops for Reversal of Mydriasis, Presbyopia and Night Vision Disturbances
For more details, click here for the full news release.